GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Evonik likely to reject BASF's sweetened $12.5 billion bid, FT reports - Finance news and analysis from Global Banking & Finance Review
Finance

Evonik likely to reject BASF's sweetened $12.5 billion bid, FT reports

Published by Global Banking & Finance Review

Posted on October 30, 2026

2 min read

· Last updated: October 30, 2026

Add as preferred source on Google

Evonik Likely to Reject BASF's $12.5 Billion Takeover Bid as Too Low

Evonik's Response to BASF's Takeover Offer

Oct 30 (Reuters) - German chemicals firm Evonik is expected to reject a sweetened €11.18 billion ($12.48 billion) takeover offer from rival BASF, deeming it too low, the Financial Times reported on Thursday, citing people familiar with the matter.

Details of the BASF Offer

• Evonik considers BASF's bid of €24 per share as undervaluing the company and could make a statement in the coming days, the report said

Potential for Future Negotiations

• Evonik could be open to future talks if BASF improves its offer further and gives more clarity on the merits of a tie-up, but currently prefers to pursue its standalone strategy, the report said

Company Reactions

• Evonik declined to comment. BASF did not immediately respond to Reuters requests for comment outside regular business hours

Background and Competing Interests

• Chemical company BASF improved its bid last week from an original €22.15 euros per share, which Evonik had rejected in September

• Evonik has also been eyeing a $3.3 billion acquisition of US specialty chemicals firm Ashland, which BASF considers too risky

Exchange Rate Information

($1 = 0.8957 euros)

Reporting Credits

(Reporting by Rodrigo Ramirez in Mexico City; Editing by Sherry Jacob-Phillips and Subhranshu Sahu)

Key Takeaways

  • BASF raised its takeover offer to €24 per share—about €11.18 billion total—including job and site guarantees—but Evonik still considers it undervaluing the company and is expected to reject it (inspectioneering.com).
  • Evonik prefers its standalone strategy for now, but could resume discussions if BASF enhances the offer further and outlines strategic benefits (inspectioneering.com).
  • Evonik’s anticipated acquisition of U.S. specialty chemicals firm Ashland (~$3.3 billion) is seen by BASF as a risky move, potentially influencing its defensive stance (inspectioneering.com).

References

Frequently Asked Questions

Why is Evonik rejecting BASF’s sweetened takeover bid?
Evonik considers BASF's €11.18 billion bid undervalued and too low to accept.
What was BASF’s improved offer per share to Evonik?
BASF raised its offer to €24 per share from its original €22.15 per share.
Is Evonik open to future negotiations with BASF?
Yes, Evonik could consider talks if BASF improves its offer and provides more clarity on the benefits of a merger.
Has Evonik commented on the takeover proposal?
Evonik declined to comment on the current takeover proposal.
What other acquisitions is Evonik considering?
Evonik is eyeing a $3.3 billion acquisition of US specialty chemicals firm Ashland.

Tags

Related Articles

More from Finance

Explore more articles in the Finance category